Haibo Su
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Haibo Su has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Ying Xu
State Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Science, Fudan University, Shanghai, China
4 shared publications Baoying Zhang
Department of Critical Care Medicine GMU‐GIBH Joint School of Life Sciences The Guangdong‐Hong Kong‐Macao Joint Laboratory for Cell Fate Regulation and Diseases State Key Laboratory of Respiratory Disease Guangzhou Key Laboratory of Prevention and Treatment of Multiple Organ Dysfunction Syndrome the Second Affiliated Hospital Guangzhou Medical University Dongfengxi Road 195 Guangzhou Guangdong 510260 China
3 shared publicationsHonghai Wang
State Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Science, Fudan University, Number 220 Handan Road, Shanghai 200433, China, and
2 shared publicationsJiaxin Huang
Department of Critical Care Medicine GMU‐GIBH Joint School of Life Sciences The Guangdong‐Hong Kong‐Macao Joint Laboratory for Cell Fate Regulation and Diseases State Key Laboratory of Respiratory Disease Guangzhou Key Laboratory of Prevention and Treatment of Multiple Organ Dysfunction Syndrome the Second Affiliated Hospital Guangzhou Medical University Dongfengxi Road 195 Guangzhou Guangdong 510260 China
2 shared publications- Shufeng Weng
State Key Laboratory of Genetic Engineering, School of Life Science, Institute of Infection and Health, National Medical Center for Infectious Diseases, Fudan University, Shanghai 200438, China
2 shared publications Baozhou Peng
From the GMU-Guangzhou Institutes of Biomedicine and Health (GIBH) Joint School of Life Science, Guangzhou Medical University (GMU), Number 195 Dongfengxi Road, Guangzhou 510000, China
1 shared publication
Latest Publications
- Open Access
- 19 November 2025
- Published by Wiley in Advanced Science
- Vol. 12 (46) , e04245
Trained Immunity Exacerbates Inflammatory Arthritis Progression via Promoting Synovial Fibroblast Ferroptotic Resistance
Trained immunity induced by β‐glucan insult drives the functional reprogramming of macrophages to the hyperinflammatory status, contributing to developing or maintaining inflammatory diseases. Inflammatory arthritis is characterized by an idiopathically hyperinflammatory response, a phenotype similar to that of trained immunity, and its etiology involves environmental factors such as β‐glucan exposure. However, whether trained immunity contributes to inflammatory arthritis progression, as well as the reciprocal interactions, remains elusive. The study shows that β‐glucan‐induced experimental trained immunity heighten inflammation and arthritis severity in collagen‐induced arthritis (CIA) rat model. Trained macrophages by β‐glucan, upon adoptive transfer, further intensify symptoms. In arthritis progression, trained macrophages reduce fibroblast‐like synoviocytes’ (FLS) lipid peroxidation, lessening sensitivity to iFSP1‐induced ferroptosis through interleukin‐1 beta (IL‐1β)/N‐acetyltransferase 10 (NAT10)/ferroptosis suppressor protein 1 (FSP1) mRNA ac4C modification. A therapeutic approach targeting trained immunity, combining low‐dose iFSP1 and Remodelin, mitigates arthritis severity and restores ferroptosis sensitivity. Additionally, this interplay between CIA induction and β‐glucan training creates a feedback loop reinforcing trained immune memory, accelerating disease deterioration. The findings highlight trained immunity induced by endogenous or exogenous insult, such as β‐glucan, as an unexplored mechanism of inflammation dysregulation in the pathogenesis of inflammatory arthritis, opening avenues for the therapeutic approaches by targeting trained immunity.
- 19 November 2025
- Published by Wiley in Advanced Science
- Vol. 12 (46) , e04245
Open AccessTrained Immunity Exacerbates Inflammatory Arthritis Progression via Promoting Synovial Fibroblast Ferroptotic Resistance
Trained immunity induced by β‐glucan insult drives the functional reprogramming of macrophages to the hyperinflammatory status, contributing to developing or maintaining inflammatory diseases. Inflammatory arthritis is characterized by an idiopathically hyperinflammatory response, a phenotype similar to that of trained immunity, and its etiology involves environmental factors such as β‐glucan exposure. However, whether trained immunity contributes to inflammatory arthritis progression, as well as the reciprocal interactions, remains elusive. The study shows that β‐glucan‐induced experimental trained immunity heighten inflammation and arthritis severity in collagen‐induced arthritis (CIA) rat model. Trained macrophages by β‐glucan, upon adoptive transfer, further intensify symptoms. In arthritis progression, trained macrophages reduce fibroblast‐like synoviocytes’ (FLS) lipid peroxidation, lessening sensitivity to iFSP1‐induced ferroptosis through interleukin‐1 beta (IL‐1β)/N‐acetyltransferase 10 (NAT10)/ferroptosis suppressor protein 1 (FSP1) mRNA ac4C modification. A therapeutic approach targeting trained immunity, combining low‐dose iFSP1 and Remodelin, mitigates arthritis severity and restores ferroptosis sensitivity. Additionally, this interplay between CIA induction and β‐glucan training creates a feedback loop reinforcing trained immune memory, accelerating disease deterioration. The findings highlight trained immunity induced by endogenous or exogenous insult, such as β‐glucan, as an unexplored mechanism of inflammation dysregulation in the pathogenesis of inflammatory arthritis, opening avenues for the therapeutic approaches by targeting trained immunity.
- Open Access
- 11 October 2024
- Published by Springer Nature in Research Square
Upregulated FSP1 by GPD1/1L Mediated Lipid Droplet Accumulation Enhances Ferroptosis Resistance and Peritoneal Metastasis in Gastric Cancer
To successfully metastasize, cancer cells must evade detachment induced cell death, known as anoikis. Unraveling the mechanisms that gastric cancer (GC) circumvent anoikis and achieve peritoneal metastasis especially during unanchored growth, could significantly improve patient outcomes. Our study reveals that GC cells exhibit increased lipid peroxidation, MDA production, and cell death during suspension culture, which can be mitigated by the intervention with liproxstatin-1 and ferrostatin-1. We discovered that oleic acid (OA) or adipocytes stimulate lipid accumulation in GC cells, thereby inhibiting lipid peroxidation and cell death. Lipid mass spectrometry confirmed an upregulation of triglyceride synthesis, indicating that the accumulation of lipid droplet may confer resistance to ferroptosis during suspension growth. In vitro assays demonstrated that OA not only induces lipid droplet accumulation but also upregulates the expression of ferroptosis suppressor protein 1 (FSP1), a process that can be abrogated by the double knockout of GPD1/1L genes. Additionally, we have demonstrated that a decrease in the ubiquitination of FSP1 in GC cells upon lipid droplet accumulation, as well as silencing or pharmacological targeting FSP1, promotes ferroptosis and disrupts the peritoneal metastatic potential of GC cells. Collectively, our findings highlight the potential of FSP1 as a promising therapeutic target for metastatic gastric cancer.
- 11 October 2024
- Published by Springer Nature in Research Square
Open AccessUpregulated FSP1 by GPD1/1L Mediated Lipid Droplet Accumulation Enhances Ferroptosis Resistance and Peritoneal Metastasis in Gastric Cancer
To successfully metastasize, cancer cells must evade detachment induced cell death, known as anoikis. Unraveling the mechanisms that gastric cancer (GC) circumvent anoikis and achieve peritoneal metastasis especially during unanchored growth, could significantly improve patient outcomes. Our study reveals that GC cells exhibit increased lipid peroxidation, MDA production, and cell death during suspension culture, which can be mitigated by the intervention with liproxstatin-1 and ferrostatin-1. We discovered that oleic acid (OA) or adipocytes stimulate lipid accumulation in GC cells, thereby inhibiting lipid peroxidation and cell death. Lipid mass spectrometry confirmed an upregulation of triglyceride synthesis, indicating that the accumulation of lipid droplet may confer resistance to ferroptosis during suspension growth. In vitro assays demonstrated that OA not only induces lipid droplet accumulation but also upregulates the expression of ferroptosis suppressor protein 1 (FSP1), a process that can be abrogated by the double knockout of GPD1/1L genes. Additionally, we have demonstrated that a decrease in the ubiquitination of FSP1 in GC cells upon lipid droplet accumulation, as well as silencing or pharmacological targeting FSP1, promotes ferroptosis and disrupts the peritoneal metastatic potential of GC cells. Collectively, our findings highlight the potential of FSP1 as a promising therapeutic target for metastatic gastric cancer.
- Open Access
- 30 November 2023
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 300 (1) , 105518
Mucosal recombinant BCG vaccine induces lung-resident memory macrophages and enhances trained immunity via mTORC2/HK1-mediated metabolic rewiring
- 30 November 2023
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 300 (1) , 105518
Open AccessMucosal recombinant BCG vaccine induces lung-resident memory macrophages and enhances trained immunity via mTORC2/HK1-mediated metabolic rewiring
- Open Access
- 7 December 2021
- Published by Elsevier in Redox Biology
- Vol. 48, 102206
Glutathione synthesis primes monocytes metabolic and epigenetic pathway for β-glucan-trained immunity
- 7 December 2021
- Published by Elsevier in Redox Biology
- Vol. 48, 102206
Open AccessGlutathione synthesis primes monocytes metabolic and epigenetic pathway for β-glucan-trained immunity
- Open Access
- 1 June 2018
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 293 (26) , 10287-10302
Mycobacterium tuberculosis PPE60 antigen drives Th1/Th17 responses via Toll-like receptor 2–dependent maturation of dendritic cells
- 1 June 2018
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 293 (26) , 10287-10302
Open AccessMycobacterium tuberculosis PPE60 antigen drives Th1/Th17 responses via Toll-like receptor 2–dependent maturation of dendritic cells
- Open Access
- 18 November 2016
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 6, 147
Recombinant Lipoprotein Rv1016c Derived from Mycobacterium tuberculosis Is a TLR-2 Ligand that Induces Macrophages Apoptosis and Inhibits MHC II Antigen Processing
TLR2-dependent cellular signaling in Mycobacterium tuberculosis-infected macrophages causes apoptosis and inhibits class II major histocompatibility complex (MHC-II) molecules antigen processing, leading to evasion of surveillance. Mycobacterium tuberculosis (Mtb) lipoproteins are an important class of Toll-like receptor (TLR) ligand, and identified as specific components that mediate these effects. In this study, we identified and characterized Mtb lipoprotein Rv1016c (lpqT) as a cell wall associated-protein that was exposed on the cell surface and enhanced the survival of recombinants M. smegmatis_Rv1016c under stress conditions. We found that Rv1016c lipoprotein was a novel TLR2 ligand and able to induce macrophage apoptosis in a both dose- and time-dependent manner. Additionally, apoptosis induced by Rv1016c was reserved in THP-1 cells blocked with anti-TLR-2 Abs or in TLR2-/- mouse macrophages, indicating that Rv1016c-induced apoptosis is dependent on TLR2. Moreover, we demonstrated that Rv1016c lipoprotein inhibited IFN-γ-induced MHC-II expression and processing of soluble antigens in a TLR2 dependent manner. Class II transactivator (CIITA) regulates MHC II expression. In this context, Rv1016c lipoprotein diminished IFN-γ-induced expression of CIITA IV through TLR2 and MAPK Signaling. TLR2-dependent apoptosis and inhibition of MHC-II Ag processing induced by Rv1016c during mycobacteria infection may promote the release of residual bacilli from apoptotic cells and decrease recognition by CD4+ T cells. These mechanisms may allow intracellular Mtb to evade immune surveillance and maintain chronic infection.
- 18 November 2016
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 6, 147
Open AccessRecombinant Lipoprotein Rv1016c Derived from Mycobacterium tuberculosis Is a TLR-2 Ligand that Induces Macrophages Apoptosis and Inhibits MHC II Antigen Processing
TLR2-dependent cellular signaling in Mycobacterium tuberculosis-infected macrophages causes apoptosis and inhibits class II major histocompatibility complex (MHC-II) molecules antigen processing, leading to evasion of surveillance. Mycobacterium tuberculosis (Mtb) lipoproteins are an important class of Toll-like receptor (TLR) ligand, and identified as specific components that mediate these effects. In this study, we identified and characterized Mtb lipoprotein Rv1016c (lpqT) as a cell wall associated-protein that was exposed on the cell surface and enhanced the survival of recombinants M. smegmatis_Rv1016c under stress conditions. We found that Rv1016c lipoprotein was a novel TLR2 ligand and able to induce macrophage apoptosis in a both dose- and time-dependent manner. Additionally, apoptosis induced by Rv1016c was reserved in THP-1 cells blocked with anti-TLR-2 Abs or in TLR2-/- mouse macrophages, indicating that Rv1016c-induced apoptosis is dependent on TLR2. Moreover, we demonstrated that Rv1016c lipoprotein inhibited IFN-γ-induced MHC-II expression and processing of soluble antigens in a TLR2 dependent manner. Class II transactivator (CIITA) regulates MHC II expression. In this context, Rv1016c lipoprotein diminished IFN-γ-induced expression of CIITA IV through TLR2 and MAPK Signaling. TLR2-dependent apoptosis and inhibition of MHC-II Ag processing induced by Rv1016c during mycobacteria infection may promote the release of residual bacilli from apoptotic cells and decrease recognition by CD4+ T cells. These mechanisms may allow intracellular Mtb to evade immune surveillance and maintain chronic infection.